Expert Review of Clinical Immunology, Volume 18, Issue 5 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Clinical Immunology, Volume 18, Issue 5 (2022)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Volume 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
What is the ideal duration of maintenance therapy for lupus nephritis?
Desmond Y. H. Yap & Tak Mao Chan
Pages: 425-427
Published online: 22 Mar 2022
First Page PreviewforWhat is the ideal duration of maintenance therapy for lupus nephritis? | Full Text | References | PDF (135.1 KB) | EPUB
  • 2611 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Special Report

Article
X marks the spot in autoimmunity
Alessio Gerussi, Chiara Caime, Eleonora Binatti, Claudio Cappadona, Laura Cristoferi, Rosanna Asselta, M. Eric Gershwin & Pietro Invernizzi
Pages: 429-437
Published online: 26 Apr 2022
AbstractforX marks the spot in autoimmunity | Full Text | References | PDF (1.8 MB) | EPUB
  • 144 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review
The suitability of treating atopic dermatitis with Janus kinase inhibitors
Shanthi Narla & Jonathan I. Silverberg
Pages: 439-459
Published online: 04 May 2022
AbstractforThe suitability of treating atopic dermatitis with Janus kinase inhibitors | Full Text | References | PDF (1 MB) | EPUB
  • 846 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
Immunologic underpinnings and treatment of morphea
Avery H. LaChance, Nathaniel Goldman, Bina Kassamali & Ruth Ann Vleugels
Pages: 461-483
Published online: 04 May 2022
AbstractforImmunologic underpinnings and treatment of morphea | Full Text | References | PDF (955.1 KB) | EPUB
  • 278 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis
Aliki I. Venetsanopoulou, Paraskevi V. Voulgari & Alexandros A. Drosos
Pages: 485-493
Published online: 09 May 2022
AbstractforJanus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis | Full Text | References | PDF (3.5 MB) | EPUB
  • 442 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Impact of immunotherapies on COVID-19 outcomes in multiple sclerosis patients
Chiara Zanetta, Maria A. Rocca & Massimo Filippi
Pages: 495-512
Published online: 27 Apr 2022
AbstractforImpact of immunotherapies on COVID-19 outcomes in multiple sclerosis patients | Full Text | References | PDF (1.1 MB) | EPUB
  • 283 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Emerging therapies for ulcerative colitis
Jurij Hanzel, Melanie S. Hulshoff, Joep Grootjans & Geert D’Haens
Pages: 513-524
Published online: 01 May 2022
AbstractforEmerging therapies for ulcerative colitis | Full Text | References | PDF (1.2 MB) | EPUB
  • 7115 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Review
Antibodies against phosphorylcholine and protection against atherosclerosis, cardiovascular disease and chronic inflammation
Johan Frostegård
Pages: 525-532
Published online: 01 May 2022
AbstractforAntibodies against phosphorylcholine and protection against atherosclerosis, cardiovascular disease and chronic inflammation | Full Text | References | PDF (308.4 KB) | EPUB
  • 1359 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial
Christian Schwabe, Andras Illes, Martin Ullmann, Vishal Ghori, Emmanuelle Vincent, Corinne Petit-Frere, Joelle Monnet, Anne Sophie Racault & Chris Wynne
Pages: 533-543
Published online: 10 Apr 2022
AbstractforPharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial | Full Text | References | PDF (770.5 KB) | EPUB | Supplemental
  • 3494 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Explore articles